Home > Publications Database > Counteraction of inflammatory activity in CAA-related subarachnoid hemorrhage. > print

001     165511
005     20231120155326.0
024 7 _ |a pmc:PMC9886617
|2 pmc
024 7 _ |a 10.1007/s00415-022-11437-9
|2 doi
024 7 _ |a pmid:36308530
|2 pmid
024 7 _ |a 0012-1037
|2 ISSN
024 7 _ |a 0340-5354
|2 ISSN
024 7 _ |a 0939-1517
|2 ISSN
024 7 _ |a 1432-1459
|2 ISSN
024 7 _ |a 1619-800X
|2 ISSN
024 7 _ |a 0367-004x
|2 ISSN
024 7 _ |a 0367-004X
|2 ISSN
037 _ _ |a DZNE-2022-01659
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Schreiber, Stefanie
|0 P:(DE-2719)2812631
|b 0
|e First author
|u dzne
245 _ _ |a Counteraction of inflammatory activity in CAA-related subarachnoid hemorrhage.
260 _ _ |a Berlin
|c 2023
|b Springer
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1676382936_8739
|2 PUB:(DE-HGF)
|x Letter
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a ISSN 1432-1459 not unique: **2 hits**.
536 _ _ |a 352 - Disease Mechanisms (POF4-352)
|0 G:(DE-HGF)POF4-352
|c POF4-352
|f POF IV
|x 0
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 1
542 _ _ |i 2022-10-29
|2 Crossref
|u https://creativecommons.org/licenses/by/4.0
542 _ _ |i 2022-10-29
|2 Crossref
|u https://creativecommons.org/licenses/by/4.0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Subarachnoid Hemorrhage: complications
|2 MeSH
650 _ 2 |a Subarachnoid Hemorrhage: diagnostic imaging
|2 MeSH
650 _ 2 |a Cerebral Hemorrhage
|2 MeSH
650 _ 2 |a Brain
|2 MeSH
650 _ 2 |a Cerebral Amyloid Angiopathy
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging
|2 MeSH
700 1 _ |a John, Anna-Charlotte
|0 0000-0001-5627-122X
|b 1
700 1 _ |a Werner, Cornelius J
|0 0000-0002-4624-7995
|b 2
700 1 _ |a Vielhaber, Stefan
|0 P:(DE-2719)2000035
|b 3
|u dzne
700 1 _ |a Heinze, Hans-Jochen
|0 P:(DE-2719)2260426
|b 4
|u dzne
700 1 _ |a Speck, Oliver
|0 P:(DE-2719)2810706
|b 5
|u dzne
700 1 _ |a Würfel, Jens
|0 0000-0002-0034-8053
|b 6
700 1 _ |a Behme, Daniel
|0 P:(DE-HGF)0
|b 7
700 1 _ |a Mattern, Hendrik
|0 P:(DE-2719)9002178
|b 8
|e Last author
|u dzne
773 1 8 |a 10.1007/s00415-022-11437-9
|b Springer Science and Business Media LLC
|d 2022-10-29
|n 2
|p 1159-1161
|3 journal-article
|2 Crossref
|t Journal of Neurology
|v 270
|y 2022
|x 0340-5354
773 _ _ |a 10.1007/s00415-022-11437-9
|0 PERI:(DE-600)1421299-7
|n 2
|p 1159-1161
|t Journal of neurology
|v 270
|y 2022
|x 0340-5354
856 4 _ |u https://pub.dzne.de/record/165511/files/DZNE-2022-01659.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/165511/files/DZNE-2022-01659.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:165511
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)2812631
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 3
|6 P:(DE-2719)2000035
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 4
|6 P:(DE-2719)2260426
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 5
|6 P:(DE-2719)2810706
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 8
|6 P:(DE-2719)9002178
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-352
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Disease Mechanisms
|x 0
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 1
914 1 _ |y 2022
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2023-10-21
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b J NEUROL : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b J NEUROL : 2022
|d 2023-10-21
920 1 _ |0 I:(DE-2719)1340009
|k AG Speck
|l Linking imaging projects iNET
|x 0
920 1 _ |0 I:(DE-2719)1310010
|k AG Schreiber
|l Mixed cerebral pathologies and cognitive aging
|x 1
920 1 _ |0 I:(DE-2719)1310005
|k AG Reymann
|l Pathophysiology of Dementia
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1340009
980 _ _ |a I:(DE-2719)1310010
980 _ _ |a I:(DE-2719)1310005
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts
999 C 5 |a 10.1212/WNL.0000000000009036
|9 -- missing cx lookup --
|1 N Raposo
|p e968 -
|2 Crossref
|u Raposo N, Charidimou A, Roongpiboonsopit D, Onyekaba M, Gurol ME, Rosand J et al (2020) Convexity subarachnoid hemorrhage in lobar intracerebral hemorrhage: a prognostic marker. Neurology 94(9):e968–e977. https://doi.org/10.1212/WNL.0000000000009036
|t Neurology
|v 94
|y 2020
999 C 5 |a 10.1161/STROKEAHA.115.008778
|9 -- missing cx lookup --
|1 M Beitzke
|p 1533 -
|2 Crossref
|u Beitzke M, Enzinger C, Wünsch G, Asslaber M, Gattringer T, Fazekas F (2015) Contribution of convexal subarachnoid hemorrhage to disease progression in cerebral amyloid angiopathy. Stroke 46(6):1533–1540. https://doi.org/10.1161/STROKEAHA.115.008778
|t Stroke
|v 46
|y 2015
999 C 5 |a 10.1093/brain/awx047
|9 -- missing cx lookup --
|1 A Charidimou
|p 1829 -
|2 Crossref
|u Charidimou A, Boulouis G, Gurol ME, Ayata C, Bacskai BJ, Frosch MP et al (2017) Emerging concepts in sporadic cerebral amyloid angiopathy. Brain 140(7):1829–1850. https://doi.org/10.1093/brain/awx047
|t Brain
|v 140
|y 2017
999 C 5 |a 10.1177/1747493020974464
|9 -- missing cx lookup --
|1 MG Kozberg
|p 356 -
|2 Crossref
|u Kozberg MG, Perosa V, Gurol ME, van Veluw SJ (2021) A practical approach to the management of cerebral amyloid angiopathy. Int J Stroke 16(4):356–369. https://doi.org/10.1177/1747493020974464
|t Int J Stroke
|v 16
|y 2021
999 C 5 |a 10.1016/S1474-4422(22)00208-3
|9 -- missing cx lookup --
|2 Crossref
|u Charidimou A, Boulouis G, Frosch MP, Baron J-C, Pasi M, Albucher JF et al (2022) The Boston criteria version 2.0 for cerebral amyloid angiopathy: a multicentre, retrospective, MRI-neuropathology diagnostic accuracy study. Lancet Neurol 21(8):714–725. https://doi.org/10.1016/S1474-4422(22)00208-3
999 C 5 |a 10.1177/1747493017741569
|9 -- missing cx lookup --
|1 A Corovic
|p 257 -
|2 Crossref
|u Corovic A, Kelly S, Markus HS (2018) Cerebral amyloid angiopathy associated with inflammation: a systematic review of clinical and imaging features and outcome. Int J Stroke 13(3):257–267. https://doi.org/10.1177/1747493017741569
|t Int J Stroke
|v 13
|y 2018
999 C 5 |a 10.1001/jamaneurol.2020.1782
|9 -- missing cx lookup --
|1 RW Regenhardt
|p 1261 -
|2 Crossref
|u Regenhardt RW, Thon JM, Das AS, Thon OR, Charidimou A (2020) Association between immunosuppressive treatment and outcomes of cerebral amyloid angiopathy-related inflammation. JAMA Neurol 77(10):1261–1269. https://doi.org/10.1001/jamaneurol.2020.1782
|t JAMA Neurol
|v 77
|y 2020

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21